Key result
Statin use linked to ~45% incidence of potential drug-drug interactions, strongly driven by MI.
Observational (n=1,061)
No
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2020) conducted an observational in Patients taking statins (n=1,061). Statins (HMG CoA-reductase inhibitors) was evaluated on Risk of potential drug-drug interactions (myocardial infarction indication) (OR 8.836, 95% CI 1.018-76.680, p=0.048). Statins were associated with a 45% incidence of potential drug-drug interactions, with myocardial infarction, arrhythmia or heart failure, and AST >40 IU/L identified as key risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: